STOCK TITAN

APH insider files Form 144 to sell 88,000 shares via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filed for Amphenol Corporation (APH) reports a proposed sale of 88,000 common shares acquired on 09/08/2025 by exercise of options under a registered plan. The filing lists Morgan Stanley Smith Barney LLC as the broker and shows an aggregate market value of $9,735,941.60 for the shares, with approximately 1,220,921,111 shares outstanding. The filer indicates payment was made in cash on 09/08/2025 and reports no other sales in the past three months. The notice includes the required representation that the seller has no undisclosed material adverse information about the issuer.

Positive

  • Full disclosure provided: filing lists broker, acquisition method, payment, and aggregate market value
  • Securities were acquired via exercise under a registered plan, indicating a standard, documented source of shares
  • No sales in the past three months reported for the account, reducing concern about recent heavy insider selling

Negative

  • Insider liquidity event: the filing indicates an insider intends to sell exercised shares, which may be viewed negatively by some investors
  • Aggregate value is sizable in absolute terms ($9,735,941.60) even though it is small as a percentage of outstanding shares

Insights

TL;DR: Insider exercised options and intends to sell 88,000 shares worth about $9.74M; transaction appears routine and disclosed.

The filing shows an option exercise under a registered plan on the same day as the reported proposed sale, indicating the shares were newly acquired and are being offered through a registered broker. The size of the position (88,000 shares) represents a very small fraction of the 1,220,921,111 shares outstanding, suggesting limited market impact or dilution. The absence of other sales in the prior three months reduces concerns about a pattern of large disposals. This is a routine Section 144 disclosure for compliance and liquidity purposes.

TL;DR: Filing complies with Rule 144 disclosure; provides transparency but signals insider liquidity.

The notice documents the mechanics (exercise of options, cash payment) and uses a major brokerage firm, which supports orderly execution. The filer’s certification that no material nonpublic information exists is standard. While the transaction is transparent and procedural, insiders selling exercised shares can be interpreted as liquidity-taking; however, given the small size relative to outstanding shares, it is not likely material to shareholders.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Amphenol (APH) disclose in this Form 144?

The filer disclosed a proposed sale of 88,000 common shares acquired on 09/08/2025 by exercising options under a registered plan, using Morgan Stanley Smith Barney LLC as broker.

How much are the 88,000 shares worth according to the filing?

The filing lists an aggregate market value of $9,735,941.60 for the 88,000 shares.

Does the Form 144 report any other recent sales by the filer?

No. The section for securities sold during the past three months states Nothing to Report.

When were the shares acquired and how were they paid for?

The shares were acquired on 09/08/2025 by exercise of options under a registered plan and payment was made in cash on the same date.

How large is the proposed sale relative to Amphenol's outstanding shares?

The filing reports 1,220,921,111 shares outstanding; the 88,000-share sale is a very small fraction of that total.